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Abstract 
Renewing Health is a European project (February 2010-December 2013), partly funded by the European Union under the 
ICT Policy Support Programme, part of the Competitiveness and Innovation framework Programme (CIP), with a total 
budget of €14 million and European co-financing of €7 million. The project aimed to implement health-related ICT 
services through large-scale real-life test beds for the validation and subsequent evaluation of innovative eHealth 
services, using a patient-centred approach and a rigorous common assessment methodology. 
This case study focuses on the Austrian Partner of the project: the Carinthia region and, more precisely, KABEG 
(Krankenanstalten Betriebsgesellschaft), the hospital management company in the region.   
In RENEWING HEALTH, KABEG integrated a set of telemonitoring solutions into their existing systems for two target groups 
- patients suffering from Diabetes Mellitus Type II and patients suffering from COPD – in order to carry out two pilots to 
test the effects of the resulting system. 
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Preface 
The Strategic Intelligence Monitor on Personal Health Systems (SIMPHS) research started in 
2009 with the analysis of the market for Remote Patient Monitoring and Treatment (RMT) 
within Personal Health Systems (PHS). This approach was complemented in a second phase 
(SIMPHS2) with the analysis of the demand side, focusing on needs, demands and 
experiences of PHS by healthcare producing units (e.g. hospitals, primary care centres), 
healthcare professionals, healthcare authorities and patients amongst others.  
Building on the lessons learnt from SIMPHS2 and from the European Innovation Partnership 
on Active and Healthy Ageing initiative, SIMPHS3 aims to explore the factors that lead to 
successful deployment of integrated care and independent living, and define the best 
operational practices and guidelines for further deployment in Europe. This case study 
report is one of a series of case studies developed to achieve these objectives. 
The outcomes of SIMPHS2 are presented in a series of public reports which discuss the role 
of governance, innovation and impact assessment in enabling integrated care deployment. 
In addition, through the qualitative analysis of 27 Telehealth, Telecare and Integrated Care 
projects implemented across 20 regions in eight European countries investigated in 
SIMPHS2, eight facilitators have been identified, based on Suter’s ten key principles for 
successful health systems integration.  
The eight main facilitators identified among these as necessary for successful deployment 
and adoption of telehealth, telecare and integrated care in European regions are:  
 Reorganisation of services 
 Patient focus 
 Governance mechanisms 
 Interoperable information systems 
 Policy commitment, 
 Engaged professionals 
 National investments and funding programmes, and  
 Incentives and financing.  
These eight facilitators have guided the analysis of the cases studied in SIMPHS3 and a 
graph showing the relative importance of each facilitator is presented in each case study. 
In addition to the above facilitators analysed in each case report, a specific section is 
dedicated to the analysis of care integration. It should be noted that the definition of 
vertical and horizontal integration used in this research is taken from the scientific 
literature in the field of integrated care.1  This definition differs from the one mentioned in 
the European Innovation Partnership on Active and Healthy Ageing Strategic 
Implementation Plan.2 We define horizontal integration as the situation where similar 
organisations/units at the same level join together (e.g. two hospitals) and vertical 
integration as the combination of different organisations/units at different level (e.g. 
hospital, primary care and social care). 
 
 
                                              
1  Kodner, D. (2009). All together now: A conceptual Exploration of Integrated Care.  
2  http://ec.europa.eu/research/innovation-union/pdf/active-healthy-ageing/steering-
group/operational_plan.pdf (page 27) 
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Case outlook 
Renewing Health was a European project (February 2010-December 2013), partially funded 
by the European Union under the ICT Policy Support Programme, part of the 
Competitiveness and Innovation framework Programme (CIP), with a total budget of €14 
million and European co-financing of €7 million. The project aimed to implement health-
related ICT services through large-scale real-life test beds for the validation and 
subsequent evaluation of innovative eHealth services, using a patient-centred approach and 
a rigorous common assessment methodology. 
It involved a consortium of 9 European regions in: Austria, Italy, Denmark, Sweden, Norway, 
Spain, Finland, Greece and Germany. One of the pre-requisites of the CIP programme for 
the projects was the existence of developed solutions that could be scaled up and tested as 
pilots. In the case of Renewing Health, the participating regions had already implemented 
some operational solutions related to the telemonitoring and the treatment of chronic 
patients suffering from diabetes, chronic obstructive pulmonary disease (COPD) or 
cardiovascular disease (CVD) at local level. The services included self-management of 
diseases for the patients, promoting compliance to treatment and helping healthcare 
professionals to detect early signs of worsening in the monitored pathologies. During the 
lifespan of the project, these existing solutions were scaled up and integrated into the local 
health information systems in order to be tested as pilots in the different project settings. 
This case study focuses on the Austrian Partner of the project: the Carinthia region and, 
more precisely, KABEG (Krankenanstalten Betriebsgesellschaft), the hospital management 
company in the region.   
In RENEWING HEALTH, KABEG integrated a set of telemonitoring solutions into their existing 
systems for two target groups - patients suffering from Diabetes Mellitus Type II and 
patients suffering from COPD – in order to carry out two pilots which aimed to test the 
effects of the resulting system. Prior to the project, KABEG already had a system in place 
for the collection of nursing data, as well as disease management processes for chronic 
patients suffering from diabetes, and to some extent for patients with COPD. The aim of 
the Carinthian telemonitoring project within Renewing Health was to establish a permanent 
infrastructure and an integrated treatment process for Diabetes Mellitus Type II and COPD 
using integrated electronic systems. The services targeted diabetes and COPD in the 
outpatient areas of three KABEG hospitals, which cooperated directly with the patient, or 
with the treating nursing homes and mobile nurses. Patients measured some parameters 
(blood sugar, blood pressure and body weight in the case of diabetes; COPD Assessment 
test and body weight in the case of COPD) every day, using blood sugar meters, scales and 
blood pressure measuring devices provided for free, for automatic transmission of 
measurement readings. Patients were empowered to do the readings themselves. However, 
in cases where patients were assisted by home nurses, the latter were trained to use the 
service for them. These measurements were automatically registered in the Health 
Information System (HIS) on a weekly basis for diabetes, monthly for COPD or immediately 
if measurement values fell outside a given range, and therefore required immediate 
attention by healthcare providers. The responsible General Practitioner (GP) checked the 
data to devise further treatment when required. Finally, a monthly report was sent to the 
patients and, if desired, to their GPs.   
Within the scope of the Renewing Health project, KABEG recruited 193 diabetes patients 
and 65 COPD patients to evaluate the system. The results of the pilots showed that 
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telemonitoring based on the previously cited variables did not improve patient outcomes. In 
terms of economic impact, although the patients in the control group generated more costs 
due to the slight difference in hospital days, results are not conclusive due to differences 
between the characteristics of the compared groups.  
The project was completed though some systems are still running: there are 11 diabetic 
patients who are still using the web portal to enter their parameters and to check their 
health progression over time. It is unclear whether the services will be mainstreamed in the 
future. Regarding COPD, as the results of the trials were not conclusive, the implementation 
of a telemonitoring solution for COPD patients was considered low priority, pending further 
studies. In the case of diabetes the results of the trials demonstrated a reduction in costs, 
but with low statistical significance. Organisational issues and costs need to be addressed 
in order to mainstream the service.  
In relation to government settings and policy, it is worth mentioning that Austria is 
preparing a Health Reform which includes eHealth and telemedicine. Until then, the 
potential regulatory changes that may occur and the possible scenarios for further eHealth 
implementation remain unclear. However, KABEG plans include the implementation of their 
system into hospitals and other institutions. KABEG aims to get at least 30 patients into 
permanent care, and a further increase (50%) of patients is planned for 2016. There are 
also pending negotiations with other health institutions, e.g. the local health insurance 
company, where the system could be used in ambulatory care. 
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1 Background 
1.1 Austria 
The Republic of Austria is a federal republic of roughly 8.5 million people in Central Europe. 
It is landlocked and bordered by the Czech Republic and Germany to the north, Hungary and 
Slovakia to the east, Slovenia and Italy to the south, and Switzerland and Liechtenstein to 
the west. The territory of Austria covers 83,855 square kilometres and has a temperate and 
alpine climate. Austria's terrain is highly mountainous, lying within the Alps; only 32% of 
the country is below 500 metres and its highest point is 3,798 metres. 
Today, Austria is a parliamentary representative democracy. The capital and largest city, 
with a population exceeding 1.7 million, is Vienna. Austria is one of the richest countries in 
the world, with a nominal per capita GDP of $46,330 .The country has developed a high 
standard of living and in 2011 was ranked 19th in the world for its Human Development 
Index. Austria has been a member of the United Nations since 1955, joined the European 
Union in 1995, and is a founder of the OECD. Austria also signed the Schengen Agreement 
in 1995, and adopted the European currency, the euro, in 1999. 
As in the rest of OECD countries, the Austrian population is still ageing, although it is in the 
final stage of this demographic transition. The proportion of under 15 year olds is expected 
to drop to 14.3% (from 17% in 2000), while the proportion of over 64 year olds is set to 
rise to 19.5% (from 15.5%) by 2020. 
As a federal republic, Austria is divided into nine states (Bundesländer). The states are not 
mere administrative divisions but have some legislative authority distinct from the federal 
government, which is responsible for health care legislation and administration of the 
Health Care System and other important issues (food safety, military, monetary and 
banking systems).  
The Constitutional Finance Law establishes a framework for financial relationships between 
the federal government, the regions and the local authorities. Moreover, it states how taxes 
are allocated at the different levels.   
1.2 The Austrian Health System 
The Austrian Health System provides universal coverage, including a wide range of benefits 
and high-quality care, to all Austrian and EU citizens. Free choice of providers and 
unrestricted access to all care levels (general practitioners, specialist physicians and 
hospitals) are characteristic features of the system. Population satisfaction is well above 
the EU average. Income-related inequality in health has increased since 2005, although it is 
still relatively low compared to other countries. The health-care system has been shaped by 
both the federal structure of the state and a tradition of delegating responsibilities to self-
governing stakeholders. On the one hand, this enables decentralised planning and 
governance, adjusted to local norms and preferences. On the other hand, it also leads to 
fragmentation of responsibilities and frequently results in inadequate coordination. This 
trend shows two main consequences: patient satisfaction, as the system provides tailored 
care depending on regional and personal demands; and budget imbalances: the costs of the 
health-care system are well above the EU15 average, both in absolute terms and as a 
percentage of GDP (10.8% vs. 10.4% in 2011) (European Commission, 2013). For this 
reason, efforts have been made for several years to achieve more joint planning, 
governance and financing of the health-care system at the federal and regional level. In 
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2005, Austria created the Federal Health Agency and regional agencies, in order to intensify 
the cross-stakeholder coordination and foster more homogeneous health care provision. 
However, as in any health system, a number of challenges remain. Table 1 presents general 
information about the Austrian Healthcare System. As shown in Figure 1 and Figure 2 
below health expenditure per capita and as a percentage of GPD are above the European 
average. 
Table 1 - General information about the Austrian Healthcare System 
Geographical coverage km2 83,871 
Inhabitants per km2 98.04 
Number of inhabitants 8,495,000 
Life expectancy at birth, years 78 males – 83  females4 
GDP (2014), billion $ 361,000 
GDP per inhabitant (2014), $ 42,600 
General Practitioners /1,000 inhabitants (2010) 4.78 
Nurses  7.83 
National Budget for Health services management (2013), 
billion $ 
40,555 
Health care professionals / 100,000 inhabitants 1,274.53 
Health care budget, € per inhabitants (2013) 5,066.02 
Hospital beds (2011) 68,758 
Hospital beds/1,000 habitants (2012) 8.2 
Source: (Hofmarcher, 2013) and WHO 
 
Figure 1 - Health expenditure per capita 
in Austria and in the Europe WHO's 
region 
Figure 2 - Evolution of health systems expenditure as 
% of GDP 
 
 
Source (Hofmarcher, 2013) 
Source (Hofmarcher, 2013)  
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According to the 2013 health system review on Austria (Hofmarcher, 2013) and WHO 
20133 data, Austrians are much more satisfied with their health system than most other 
Europeans. This could be explained by the high level of coverage and provider choice that 
Austrian patients generally enjoy and by the decentralised planning and governance that 
allows the system to cater for local needs and preferences. 
Nevertheless, there are important structural imbalances in healthcare provision, with an 
oversized hospital sector and insufficient resources for ambulatory care and preventive 
medicine. Austria also has stark regional differences in utilisation, in both curative and 
preventative services, including hospital beds, specialist physicians, outpatient 
rehabilitation, psychosocial and psychotherapeutic care and nursing. There are clear social 
inequalities in the use of medical services, such as preventive health check-ups, 
immunisation or dentistry. One of the key weaknesses of the health-care system stems 
from the scarce funds allocated to the prevention of illnesses and conditions. Spending on 
preventive medicine, at 2% of total health spending, is significantly lower than the EU15 
and OECD average (both 3%) (Hofmarcher, 2013), and also has a below-average rate of 
growth. It remains to be seen whether the focus on health promotion and prevention of the 
'framework health goals' approved in 2012 will be translated into precise measures, 
whether clear responsibilities for implementation can be assigned, and whether sufficient 
funding will be made available. This would probably improve the health of the Austrian 
population and would help to reduce costs associated with preventable diseases. 
This lack of investment in prevention may have been the trigger for the increased incidence 
of preventable diseases. Consequently, non-infectious preventable diseases such as 
cardiovascular problems and neoplasms associated with smoking are important causes for 
hospital stays and death in Austria. Life-style habits may also affect this trend, especially 
in young people (27% of Austrian 15-year-olds smoke, 17% in OECD). Moreover obesity 
rates have increased remarkably in the last years (the prevalence rate of obesity in adults 
has increased from 8.5% to 12.8% in the period 1990 - 2010) (OECD, 2012).  
The Federal Constitutional Law stipulates that responsibility for regulation of most health-
care system areas lies primarily with the federal government, which handles it through ‘the 
Federal Ministry for Health issues’. The latter is responsible for the supervision of hospital 
and ambulatory care and related legislation. Nevertheless, the Regional Health Funds are 
the operating bodies in hospital care, and they must ensure hospital bed capacity and 
financing.  
Each Federal State has its own governing body, called the Regional Health Platform, in 
which all the relevant stakeholders are represented (Federal Government, Land, local 
authorities and Chambers of Physicians). 
In the ambulatory and rehabilitation sectors, as well as in the field of medication, 
healthcare is organised through negotiations between the 22 Social Security Institutions or 
the Federation of Austrian Social Security Institutions on the one hand, and the Chambers 
of Physicians and pharmacy boards (which are organised as public law bodies), the 
statutory professional associations of midwives and other healthcare professions on the 
other. This cooperation works within a legally-defined framework to safeguard care and the 
financing of care. In some fields, social health insurers fulfil their obligation to ensure care 
provision through their own facilities. Social Security Institutions work as self-governing 
bodies, and cover some services like health insurance, pension benefits and work accident 
                                              
3  http://www.who.int/countries/aut/en  
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insurance. On the basis of agreements (‘state contract’), the federal and regional 
authorities are mutually obliged to safeguard health-care provisioning in their areas of 
responsibility. 
There are other important institutions involved in the implementation of health care: 
 The Supreme Health Board which is a medical-scientific committee which advises 
the Health Ministry on medical questions.  
 Gesundheit Österreich GmbH (GÖG), the institute for research and planning for the 
health care system which is divided into three sections: the Austrian Federal 
Institute for Health, the Healthy Austria Fund and the Federal Institute for Quality in 
the Health Service.  
 The Austrian Agency for Food and Health Safety (AGES) which is mandated at 
national level to carry out a variety of tasks in the field of food safety.  
 The Federal Health Agency, a public fund and a separate legal entity at federal level. 
The Federal Health Agency is the central facility for superregional and cross-
sectional planning, governance and finance of the healthcare system. Federal 
resources are distributed by the Federal Health Agency to the nine regional health 
funds in accordance with a pre-agreed schema, established by the Federal Health 
Commission. 
 The Federal Ministry of Labour, Social Affairs and Consumer Protection which is 
responsible for matters relating to social security, with the exception of health and 
occupational health insurance. 
 The Federal Ministry of Science and Research, responsible for university education 
of physicians and for the legal and structural management of universities offering 
medical training 
 The Federal Ministry of Finance which is responsible for taxation, budgeting, 
financial markets and financial equalisation, among others.  
This decentralisation may generate fragmentation and lack of coordination, which makes 
the Austrian health system more costly than average and could hamper its performance. 
This is why there has been on-going reform since 2005, which has led to the creation of 
the Federal Health Agency and regional health platforms in order to intensify cross-
stakeholder coordination at all levels and promote outpatient care. Figure 3 below shows 
an overview of all the different healthcare-providing bodies in Austria and their 
relationships. 
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Figure 3 - Flowchart of Health Care Responsibilities in Austria 
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The economic model of the Austrian health care system is supported mainly by two funding 
sources (Hofmarcher, 2013): 
 Public funding (77.5% of total expenditure): These funds come from taxes and 
social insurance contributions. 99.9% of the Austrian population is a member of a 
health insurance company. Membership depends on the place of residence and 
profession, so the insurance companies do not compete for funds.  Every member in 
the system has the right to access a broad set of services. Nevertheless, some of 
them require an extra payment (e.g. prescriptions). People fulfilling specific criteria 
related to their social circumstances are exempted from paying these charges.  
The guiding principle behind the system is that the provision of treatment must be 
sufficient, appropriate and should not exceed what is necessary. 
 Private funding (22.5% of total expenditure): the Austrian population is entitled to 
contract extra health care services with private health providers. Some health 
insurance companies offer their members the possibility to choose a particular 
physician and better hospital facilities.  
Payment of providers differs depending on the source of financing and the type of provider. 
Public and non-profit-making hospitals providing statutory services receive a DRG4-based 
budget. Most health insurance funds use a mixed payment system, combining flat-rate 
payments (per patient, per quarter – basic service compensation) and fee-for-service 
payments to pay for ambulatory services provided to their members. The composition of 
health spending is as follows: 
 43% for inpatient care (much higher than the OECD average). Austria has 
acknowledged that the inefficiency of its prevention plans might be the cause of 
this trend. 
 26% - ambulatory care 
 17% - pharmaceutical products 
 7.1 % - long-term care at home 
 3.6% - administration of health care. 
 1.5% - prevention 
 1.2% - organisation 
 1% - patient transport 
As reported in Statistics Austria 2011 (Statistics Austria, 2011), the total public health 
expenditure in Austria in 2010 amounted to €23,689 million (94.7% of the total health 
budget) in 2010. The remaining €1,326 (5.3%) are invested in anticipating future needs 
and in research. More specifically, €456 million are dedicated to health research. These 
funds are allocated to support the clinical overheads of the three university hospitals and 
their research staff. This support has grown at a rate of 5.7% per year since 2005 
(Hofmarcher, 2013).  
 
 
                                              
4  Disease Related Group 
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Figure 4 - Funds Origin 
 
Source: Hofmarcher, 2013 
In order to optimise healthcare provision in Austria, both the national Government and 
other stakeholders have created a legal framework that aims to facilitate the integration of 
ICT solutions into healthcare provision. The Health Reform Act of 2005, including the 
‘Health Telematics Act’, defines the legal basis for implementing eHealth services in Austria. 
The first successful case of eHealth was the implementation of an e-card system back in 
2005. Up to 8 million beneficiaries and 12,000 general practitioners were provided with an 
e-card comprising basic administrative data about the beneficiary (i.e. name, academic title, 
insurance number, card serial number and user group identification). The e-card works 
mainly as an e-Identification system, and provides access to other applications that require 
secure patient identification. The e-card does not store any medical or other health-related 
data.  
The ELGA (Elektronischer Gesundheitsakt) Act, passed in Austria in 2012, creates the legal 
basis for the country’s first national Electronic Health Record infrastructure, which will 
provide semantic interoperable sharing of several types of medical documents amongst 
Austrian healthcare providers. The ELGA system will not involve the central storage of all 
patient data. Instead, the service will only maintain a centralised registry of the locations of 
individual-related health data. Health data are defined as personal data that provide 
information about the physical or psychological state of an individual, including the data 
collected to assess the individual’s state, as well as data collected for the purposes of 
preventive medicine or healthcare provision, for diagnosis, treatment or care methods, for 
provision of care, prescribed or taken medicines, medical aids, etc. In addition, the ELGA will 
comprise information about living wills, powers of attorney and a “patient summary” based 
on the application of patients’ rights in cross-border healthcare. The ELGA system consists 
of the following components: 
1. Patient Index, 
2. Healthcare Provider Index, 
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3. Registry, 
4. Data Storage, 
5. Access Control Centre, 
6. Logging System, 
7. E-Health Access Point.  
The health data stored in the ELGA system will make health data in electronic format 
available to authorised EHR-Healthcare Providers and EHR-Participants, without reference 
to location and time. The Austrian Ministry of Health will operate an Electronic Health-
Directory Service (EHDS) that will (1) support the legitimate use of health data in electronic 
format, (2) improve information about health-related services, and (3) support planning 
activities and reporting. EHR-Healthcare Providers will be registered with the EHDS by 
authorised registration bodies, under the responsibility of the Federal Ministry of Health 
and the Federation of Austrian Social Insurance Carriers.  
According to the ELGA Act, the following data should be available for hospitals, the General 
Accident Insurance and care institutions from 1 January 2015: 
1. Clinical discharge reports from hospitals. 
2. Laboratory results. 
3. Results of diagnostic imaging by members of the medical profession. 
4. Medication data, by members of the medical profession. 
5. Medication data, by pharmacies or drug dispensing doctors at dispensation. 
6. Other results. 
From 1 July 2016, this information should be available for pharmacies, freelance doctors, 
group practices and authorised independent clinics. From 1 July 2017, private hospitals 
should be integrated into the ELGA system. According to the law, living wills, powers of 
attorney and authorised data of the medical registers should be integrated by 1 January 
2017. Finally, on 1 July 2022, freelance dentists, dental group practices and independent 
dental clinics should be integrated. As of today, physicians are obliged to introduce data 
about the patients they attend in the common health data repository. 
1.3 Carinthia region  
Carinthia (German: Kärnten) is in the Eastern Alps in the southernmost Austrian state 
(Land). Carinthia has 560,000 inhabitants, about 1,000 physicians in the outpatient area 
and some 950 hospital physicians. There are 11 hospitals of different sizes and 
specialisations, 12 homecare organisations and nearly 60 care units for citizens who need 
care, often older people.  
In 2000, the Carinthian Regional Health Board started a project to establish coordinated 
telemedicine in Carinthia. The main goals were to implement or provide:  
 Teleradiology between different hospitals in acute (1,100 cases a year) and routine 
cases, 
 A description of former treatments (about 1,400 a year), also provided by 
radiological institutes,  
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 A Carinthian (in-)patient record (>800,000 patients with 3.8 million hospital stays), 
 Secure clinical records for the outpatient area (more than 50,000 a year, strongly 
increasing).  
In Carinthia, the collection of clinical data in homes is currently in place as part of the 
homecare assistance package for patients suffering from chronic diabetes and COPD. 
However, the use of remote patient monitoring systems is not foreseen. Measurements are 
taken with traditional medical devices without communication facilities and are manually 
entered into a PDA for later transmission to the relevant hospital.  
In addition, the regional Ministry of Social Affairs implemented a GPRS/UMTS-based mobile 
documentation system for homecare treatment, using centralised storage and 
communication between the providers involved. These include 12 nursing organisations 
with about 1,500 employees, which provide about 880,000 hours of assistance to 
thousands of patients, many of whom are chronically ill. These organisations are co-
financed by the Carinthian Government. The staff of all these organisations currently uses 
the same mobile system to collect and transmit data from patients’ homes. 
1.4 KABEG  
KABEG (Landeskrankenanstalten-Betriebsgesellschaft) is the company that manages the 
five regional hospitals of Carinthia (Klagenfurt, Villach, Wolfsberg, Laas and the Gailtal 
Clinic). They have 2,700 beds for regular patients and 266 for chronic patients. Its 6,350 
employees provide inpatient care for 70-80% of the Carinthian population. It is a body 
constituted under public law with its own legal status. It was founded under the Hospital 
Operations Act of 25.2.1993 (now the Carinthian Hospital Operations Act or KABEG). KABEG 
manages and controls the use of funds in the interests of the taxpayer, by strictly adhering 
to commercial guidelines and the objectives set by the regional government. The main 
focus is on the management, co-ordination and continued, dynamic development of the 
region’s hospitals, with particular emphasis on investment planning and organisational 
development5. 
As a company working within the healthcare market, KABEG undertakes to safeguard core 
medical and nursing skills with a fully operational risk management system.  
In 2002, the Regional Health Board of Carinthia established a Coordinating Unit for all 
Carinthian e-health and telemedicine activities. Since then, KABEG has worked on the 
design and implementation of new initiatives in this field. Moreover, KABEG has been the 
main coordinator of this Unit in which physicians, public insurance companies, social service 
departments and delegates from different healthcare organisations were also involved. 
Three hospitals from KAGEG have participated in Renewing Health: Klagenfurt, Laas and 
Villach. In addition, six outpatient care clinics, two nursing homes and one mobile nursing 
organisation have collaborated.  
The aim of the pilot in Carinthia was to establish and extend the services and infrastructure 
required to manage and assess chronic patients with COPD and Diabetes. A few patients 
are still using the system and KABEG has plans to further expand the services. 
                                              
5    Information provided by KABEG 
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2 Integrated care analysis 
2.1 Dimensions of integration 
KABEG was responsible for the implementation of the Renewing Health project in Carinthia. 
The pilots conducted by KABEG as part of the Renewing Health project that focused on two 
target groups: Type II Diabetes Mellitus (T2DM) patients and Chronic Obstructive Pulmonary 
Disease (COPD) patients. Most of the professionals (Diabetes and COPD physicians, home 
nurses, etc.) who were involved in the project worked for KABEG. In addition, mobile nurses 
from the Austrian Red Cross and independent General Practitioners (GP) also participated in 
the initiative. From the beginning, KABEG defined the responsibilities of each professional 
for the remit of the project. For instance, independent GPs did not have access to the 
patient’s history and his or her physiological parameters but were informed about the 
health condition of the patients by the hospitals' outpatient departments. 
For the lifespan of the project, one can say that there was some integration between the 
three different hospitals from KABEG, and also between the other professionals and 
institutions, and KABEG played a central role in coordinating the initiative. The type of 
integration consisted mainly of information sharing and the clear definition of 
responsibilities amongst professionals, while organisational mechanisms remained 
separate.  
In order to support the flow of information among the different organisations involved in 
the project, KABEG developed a set of guidelines on communication and cooperation 
between mobile nurses, home nurses, general practitioners and GPs in the outpatient area. 
Moreover, a framework was created to integrate different Health Information Systems and 
different services. This framework included the devices that acquired and automatically 
transmitted information about physiological parameters (HbA1c, blood sugar, blood 
pressure for diabetes) to the HIS; CDA documents that ensured the integrity and security of 
the information; a call centre for supporting COPD patients; dedicated software installed on 
the mobile nurses’ PDAs that allowed them to upload patient data and, finally, the web 
portal, that allowed patients to upload their parameters and supported them with reports 
and reminders. Doctors in the outpatient area could use the platform to check the health 
status of patients and to change Disease Management Processes (DMP). These changes 
were recorded in reports and shared with the GPs in Primary Care and with the nurses 
involved. 
2.2 Impact 
The main objective of the Renewing Health pilots in Austria was to test the effects of 
integrated services on patients’ quality of life, clinical parameters and patients’ satisfaction 
and to evaluate organisational framework and economic aspects, through a randomised 
controlled trial. 
As requested by the Renewing Health project, the Model for Assessment of Telemedicine 
(MAST) (Kidholm, 2012) approach was used to assess the impact. The results are described 
in a publicly-available summary report (Steinberger H, 2014) and in two more detailed 
internal reports that were used to generate this case study.  
Regarding the impact on patient outcomes, quality of life - measured through the SF36 
questionnaire (Jenkinson, 1993) (Ware, 1992) - was the primary clinical outcome 
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considered. In addition, as a proxy for diabetes control, HbA1c6 levels were measured and 
for COPD, the St. George’s Respiratory questionnaires7 were used. As secondary outcomes, 
the number of hospitalisations and clinical visits, and patient acceptance were measured.  
Patient acceptance was evaluated using the Service User Technology Acceptability 
Questionnaire (SUTAQ) (Newman, 2011). This questionnaire includes 22 items (or 
questions) expressed on a 6-point Likert scale (from 1= ‘Strongly agree’ to 6= ‘Strongly 
Disagree’). The dimensions evaluated comprise Utility, Effect on health status, Effects on 
access to care, Effect on healthcare / social care, Privacy, Suitability and Satisfaction. The 
patients in the intervention group answered this questionnaire after 3 months and again 
after 12 months.  
For diabetes, KABEG carried out a randomised controlled parallel-group unblinded trial in 
the 3 hospitals. 193 Type II Diabetes Mellitus patients (older than 18 and with HbA1c >= 
6.5) were recruited, out of which 162 completed the study: 101 (out of the 117 recruited) 
in the intervention group and 61 (out of the 76 recruited) in the control group. Data were 
collected at the beginning of the trial, during the study period and one year after start. 
The SF36 questionnaire was used and HbA1c levels were measured at the beginning of the 
study and after 12 months for both groups, in order to evaluate the primary clinical 
outcome of the new intervention. The results did not show any significant differences 
between groups as a result of the intervention (see Table 5 in Annex). Besides, secondary 
clinical outcomes such as cholesterol levels, body weight, Body Mass Index (BMI), blood 
pressure and triglyceride levels were also monitored. For those variables, no significant 
effect was found as a result of the intervention (see Table 6 in Annex). Overall, it can be 
concluded that from a clinical point of view, the new services based on telemonitoring did 
not bring any statistically significant differences in any of the clinical variables assessed.   
KABEG did not register any remarkable impact on the number of clinical visits. Especially in 
the case of Diabetes, patients still had to visit primary care in order to monitor and assess 
their HbA1c levels every three months. This made it difficult to assess the use of services 
since both groups attended the clinical centre very often, no matter how they felt. Thus, in 
order to evaluate the impact another measure would be needed.  
The evaluation of patient acceptance using the SUTAQ questionnaire, which patients in the 
intervention group answered after 3 and 12 months (see results in Table 7 Annex), showed 
an improvement in how patients perceived quality of care during the study. Personal 
concerns were moderate and improved during the study.  Satisfaction was high throughout 
the study, although patients did not find the service suitable as a substitute to actual care. 
In addition, 65 COPD patients (COPD Gold Class III or IV) were included in the study: around 
one third in the control group (28 patients) and two thirds in the intervention group (37). 
These low numbers reflect the difficulties linked to the recruitment of COPD patients, 
whose advanced age and fragile health condition usually mean a relative lack of interest in 
participating and lack of skills to use the system. Data were collected at the beginning, 
during the treatment process and at the end of the trial after one year. Baseline 
characteristics showed significant differences between the intervention and the control 
group, making it difficult to generalise the results.    
                                              
6  http://www.nlm.nih.gov/medlineplus/ency/article/003640.htm  
7  http://www.thoracic.org/assemblies/srn/questionaires/sgrq.php  
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In the COPD trial, the SF36 and St. George’s Respiratory questionnaires analysis did not 
show differences between groups (see Table 8 and Table 9). Again, no differences were 
found in the frequency of visits. Regarding patient acceptance (see Table 10), the results 
suggested that how the care received was perceived was rather good at the start but 
worsened significantly after one year, meaning that the degree of satisfaction with the care 
received decreased. Patients’ views on whether the service should become a substitute for 
traditional care also deteriorated over time. On the other hand, patients' concerns and 
privacy issues remained quite moderate during the use of telemonitoring. The decreased 
satisfaction could therefore be related to organisational changes and to the way eHealth-
supported treatment was provided in the clinics involved. 
For the evaluation of the economic impact, the societal perspective was chosen, which is 
the most comprehensive as it includes all costs related to hospital, general practitioners, 
medical specialists, patients and their relatives. Table 11 in Annex gives an overview of the 
type of costs considered in the analysis, the methods for data collection and the 
estimations obtained at patient or group level.  
KABEG carried out a cost-minimisation analysis (CMA) on both the control and intervention 
groups, which was based on the assumption that the outcomes were equivalent in each 
group in order to determine the least-cost alternative (see Table 2). 
Table 2 - Least-cost table, DIABETES and COPD 
 Intervention Control 
Total running costs DIABETES €2,006.33 €2,120.93 
CMA=min(Ct-Ca) -€114.60 
Total running costs COPD €6,056.73 €7,674.63 
CMA=min(Ct-Ca) -€1,617.90 
 
During the Renewing Health project, it was estimated that a patient of the control group 
generated an extra €114.60 costs per year in the case of diabetes and €1,617.90 per year 
in the case of COPD. These costs included intramural (inpatient days, outpatient visits), 
extramural (visits at the general practitioner and the medical specialist) and, for the 
intervention group, telemonitoring (devices, visitations) costs (see Table 12 in Annex.  
As shown in Table 13 in Annex, the greatest difference between control and intervention 
groups related to inpatient stays. Patients in the control group incurred more stays with 
more bed-days, which was particularly the case for patients with COPD. However, because 
of the differences in the baseline characteristics these results are not conclusive. 
2.3 Drivers and barriers 
The main drivers of the case are technology on the one hand and the fact that specific 
funding was received to develop and pilot the services on the other. 
KABEG aimed to build and maintain an interface which would be as simple as possible. This 
is an important point, as the users and the target population are older people who might 
not be able to handle complex systems. In addition, KABEG built the services upon an 
already existing and running HIS. The three hospitals were already using a robust 
information system. The integration of the new data and communication platform was 
therefore easy from a technological point of view. Moreover, the professionals involved 
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were used to this ICT environment and the training they received was neither too 
complicated nor too time consuming.  
Besides, despite the complexity of the Austrian Health System and the multiple funding 
sources, sufficient funding was made available according to the experts consulted. The 
regional government was committed to the initiative and insurance companies supported it 
from the very beginning.   
With regard to barriers, the lack of a specific board for telemedicine applications hindered 
the implementation of the initiative. Problems related to the initial workload, technical 
support, the coordination of the involved organisations, and patient motivation would have 
been easier to deal with through a managing body. 
Another crucial barrier was the recruitment of patients, especially in the case of COPD. 
Patients must be carefully recruited for the treatment to be successful. Their age and 
cognitive capacities must be considered, as they have to deal with technology. Moreover, 
they have to be willing to join the initiative and participate actively. In addition, COPD 
patients are generally older, and their health status is worse than that of diabetes patients, 
so recruitment in this population group was more difficult.  
The additional workload was also underestimated. The Renewing Health services did not 
substitute any other running service but constituted an additional task in the professionals’ 
daily activity which raised concerns or even complaints.  
The initiative also encountered some difficulties with the introduction of new protocols. 
Clinical partners already used disease management protocols to treat chronic patients, 
which made it difficult to introduce new disease management protocols, especially with 
regard to the frequency of physiological parameter data collection and the amount of 
stored data. The integration of physiological parameters of chronic patients in the hospital 
information system is seen as an advantage, but established standard organisational 
procedures are not easy to change. Some stakeholders are less willing to change than 
others which can hinder further development.  
In addition, participating in studies often means additional tasks which usually come with 
direct additional resources. This was not the case in Renewing Health, sometimes making it 
difficult to involve some professionals.   
The lack of official communication standards amongst the involved institutions also 
hindered implementation. KABEG created ad hoc standards for the remit of the project, but 
if the service were to be mainstreamed, this would have to be revised and agreed upon. It 
was particularly difficult to coordinate home nurses and Red Cross nurses, which resulted in 
disruptions to patient care.  
Finally, defining a funding model for a health service in Austria is complex as it is a Federal 
State with many political levels and involving many different entities. For instance, 
hospitals are financed by the central government, the region and public insurance 
companies. Home nursing is financed by the regional government and mobile nursing is 
financed by the region and by patients. Outpatient care is supported by public insurance 
companies. Indeed, this complex system delayed the implementation of Renewing Health.  
As mentioned before, the results of the pilots carried out within the Renewing Health 
project are not conclusive enough to warrant the integration of the telemonitoring system 
into routine practice. Although the pilots demonstrated some cost reductions in the case of 
patients with diabetes, the return on investment that might result from the integration of a 
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telemonitoring solution into routine practice is unclear. So far, there is no dedicated funding 
for eHealth or telemonitoring activities although there is ongoing work to create 
agreements between the Austrian government and the various regional governments, 
which might enable and facilitate eHealth implementation. These agreements will be 
common for all national and regional eHealth initiatives and will address all health 
providers in all regions. One of the main goals of these agreements is the use of ICTs to 
facilitate cooperation, coordination and understanding among different bodies, which has to 
be achieved by 2016. 
2.4 Health professional and patients 
The professionals involved in the pilot project included practitioners from the 3 KABEG 
hospitals, the Austrian Red Cross home nurses and independent General Practitioners.  
The nurses and specialists at the hospitals were responsible for recruiting the study 
participants, while nurses from the Red Cross delivered home care. Specialists were 
responsible for reviewing the digital reports of the data submitted by the patients, for 
inviting them to additional examinations if necessary, and for informing them about their 
health status.  
Professionals from KABEG and the Austrian Red Cross received specific training prior to the 
start of the project. Home nurses of the Austrian Red Cross received an introduction and 
training into the new functions of the updated PDA system and additional devices 
(Bluetooth blood pressure and blood glucose measurement devices) together with the new 
version of their system. Professionals in the hospitals were trained for the system changes 
made to the usual hospital software. These changes were minimal and therefore only 
required a short introduction. Medical doctors received individual training of around 75 min 
and nurses of around 45min. 
The perception of professionals about the new telemonitoring system was analysed by 
KABEG through focus interviews carried out in two groups (one composed of health 
professionals and the other of technical and organisational support staff) and through 
questionnaires. In general, professionals had a good perception and acceptance of the 
telemonitoring system. However some issues arose such as usability problems with the 
Active Devices and the additional workload that the implementation of the Renewing Health 
system generated. 
Patients were considered by KABEG as central to the project and as people who must be 
treated in a special way. Like every project involving people, Renewing Health had to ensure 
that all the principles of bioethics and medical ethics were fulfilled. The project complied 
with the ethical principles included in Table 3 (see Section 2.6). 
2.5 Information and Communication Technologies 
The implementation of the Renewing Health integration strategy is based on the 
incorporation of Personal Health Systems into the existing Health Information Systems, 
expanding the functionalities to collect, send and receive CDA (i.e. Clinical Document 
Architecture) standard documents. These CDA documents enable and facilitate the 
communication between stakeholders (through the health portal and the mobile nursing 
system) and with the rest of the Austrian health system. 
KABEG had already developed its own Health Information System in the three hospitals 
under its responsibility prior to the start of the project. In addition, three other companies 
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were involved in the development of the IT infrastructure. The Carinthia State was 
responsible for organisational tasks such as the coordination of all the entities and 
providers working on the IT system. Moreover, the State’s IT department hosted and 
handled the Health Web Portal, which was developed by Groiss Informatics. Ilogs, an 
Austrian telemedicine company, developed the PDA Software for mobile nursery (called 
Mocca). 
A1 Telekom Austria, the leading mobile and communication operator in Austria supported 
the project by providing KABEG’s hospitals and the recruited COPD patients with the devices 
they needed to implement the intervention. Moreover they built the network for data 
exchange, installed the devices at the patients' homes and offered support from their 
technical department in order to ensure proper functioning8.  
All communications were supported through an internal Internet-based network, a call 
centre and SMS (reminder for patients). Users and professionals were assigned an account 
and credentials to enter the web portal. Each web portal user had access to certain areas. 
Patients had access to some information regarding their treatment, while physicians were 
only given access to the history of those patients under their responsibility. 
 
Figure 5 - Data Flow in KABEG's ICT infrastructure 
 
Source: KABEG 
 
As illustrated in Figure 5, the information was collected at the patient’s home in four ways: 
1) through the Active Devices, which automatically sent the information to the HIS; 2) via 
nurses’ PDAs; 3) by manual collection with traditional devices, the data being entered into 
                                              
8, http://www.a1.net/newsroom/en/2011/05/a1-telekom-austria-unterstutzt-e-health-initiative-innovatives-
eu-projekt-offnet-karnten-die-tur-in-gesundheitsversorgung-der-zukunft/ 
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the web portal via a personal computer or a smartphone; and 4) via the Call Centre, for the 
oldest patients. 
All this information was sent to the Automatic Collecting System, which generated a CDA 
document. This document was subsequently stored in each patient history file in the HIS, 
and made available to the physicians in the outpatient area and the GPs. This information 
was used for Disease Management Process fine-tuning. Moreover, patients could see 
statistics in the web portal, which gave them an overview of their health condition. 
However, in order to get full information about their health condition, patients 
communicated with the outpatient departments. 
The Mocca application was developed by Ilogs for the mobile nurses from the Red Cross to 
help them look after chronic patients during the Renewing Health pilot. The application 
included: 1) the Mocca planning module (i.e. the working schedule, resource management 
and route optimisation); 2) the Mocca mobile device, which allowed nurses to take 
measurements from patients; and 3) the Mocca care application which included healthcare 
documentation based on existing technical standards. KABEG’s idea is to scale up its HIS 
and electronic network to the whole Austrian hospital health care system, ELGA. Indeed, the 
development of the KABEG HIS was aligned with ELGA in order to ensure better integration 
in the coming years when ELGA is ready. However, the Renewing Health project per se will 
not be not integrated  
2.6 Governance and policy setting 
To set up and run the project, KABEG defined the governance model and the processes to 
be followed by all stakeholders and the role of each professional involved. The legal 
framework did not have to be modified to implement the project since the Austrian legal 
system already supported eHealth activities. However, in order to continue in the future, 
some specific legislation may be needed to regulate communication and cooperation 
among the different tiers of healthcare. There is also a need for legislation to guarantee 
patients security and safety. A Health Care Reform is currently under discussion. This 
reform would affect the system at national level, and might be a trigger for scaling up 
projects such as Renewing Health. The Austrian government is cooperating with the regional 
Health Departments to design this Health Care Reform which will define regulations that 
clarify issues related to eHealth amongst others.  
KABEG wanted to ensure compliance with certain ethical issues from the very beginning 
which is why they included guidelines in their initial protocol to that effect (see Table 3).  
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Table 3 - Ethical issues9 
Issue How the issue was 
addressed 
Implementation 
Patient autonomy Consent to treatment A patient information pack was created, staff 
were trained to deliver oral guidance on the 
written information, and patients’ consent was 
recorded in writing. Patients could withdraw after 
considering the written guidance at any time. 
Access and equality Public information in different 
formats; available in clinics or 
hospitals 
 
Privacy and security Consent to treatment  Cultural, religious and ethical issues are not 
included; SUTAQ provided insights into patients’ 
perception about these topics.  
 
Autonomy Different kinds of 
telemonitoring and reminder 
systems were implemented, 
but no enforcement was 
foreseen 
The patient had the possibility to choose the tool, 
and to decide whether to receive reminders or 
not.  
 
Assessment of risk 
and benefit 
Inclusion criteria and training  
 
KABEG developed the telemonitoring application and the study pilot in compliance with the 
existing legal framework. They aimed to comply with their social objectives and fulfil 
patients’ rights, while avoiding possible future liability problems (see Table 4).  
 
Table 4 - Legal issues10 
Issue How the issue was 
addressed 
Implementation 
Clinical accreditation Only staff in the selected 
clinics participated 
 
Device certification CE certificate Only devices accepted by public insurance were 
supported 
Information 
governance 
Only for systems already in 
use or systems subject to 
agreement  
Special privacy and security agreements 
Use of citizen card for User and patient 
identification possible 
Use of Information security systems by providers 
Professional liability Liability insurance Treatments involving the use of telemedicine 
included 
The project received strong support from policy makers who are working on plans for the 
possible implementation of ICT-based solutions, especially for diabetes, cardiovascular 
diseases and social care. 
 
 
                                              
9  Internal report provided by KABEG 
10  Internal deliverable provided by KABEG 
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2.7 Organisation and processes 
The implementation of Renewing Health in Carinthia was possible thanks to the cooperation 
of several organisations, under the leadership of KABEG. KABEG had the initial idea, 
recruited all the stakeholders, coordinated the initiative and made it possible to implement 
telemonitoring within the disease management processes in Carinthia. Moreover, most of 
the care professionals who were involved in the project worked for KABEG (the Diabetes 
and COPD physicians, home nurses, etc.).  
The European Commission also played a key role in Renewing Health by financing 50% of 
the total budget for implementation (€400,000). The Austrian government and the 
Carinthia regional government support hospital system funds. They also established 
specific goals for the use of ICT in care provision as a way of reducing expenditure. Public 
Insurance Companies and Social Security Institutions also contributed to the Renewing 
Health project by providing outpatient care services and by financing part of hospital care.  
Some technology companies were also involved in Renewing Health. They created, ran and 
maintained the Health Information System, the system for data collection and the 
electronic network which enabled personalised care provision. A1 Telekom designed and 
provided users with the measuring devices (Active Devices) and later developed the 
application for smartphones. Gross Informatics built the web portal for data collection and 
physician-patient communication. Ilogs developed the MOCCA application that was used by 
mobile nurses on their PDAs. 
Finally, the Austrian Red Cross managed mobile nursing, with resources from Public 
Insurance Companies and private contributions. Independent General Practitioners (GP) did 
not get strongly involved in the initiative. KABEG gave them access to patients' history and 
physiological parameters in order to ensure good disease management and support 
decision making. Figure 6 illustrates the cooperation among all the above stakeholders.  
Figure 6 - Organisations involved [authors’ creation] 
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As coordinator of the initiative, KABEG developed a common Disease Management Process 
(thereafter DMP) that had to be supported by the overall system. This DMP was developed 
in collaboration with health professionals, mainly from KABEG, and all participating 
stakeholders were later trained in its implementation. Some changes were needed in order 
to enable the implementation of the new disease management process in all involved 
organisations. First of all, the involved organisations had already established protocols for 
dealing with chronic patients. The new DMP affected these protocols, especially the 
frequency of vital parameter data collection which also determined the amount of stored 
data. The integration of vital parameters on chronic patients in the hospital information 
system was seen as an advantage, but the modification of established standard 
organisational procedures was met with some resistance.  
In order to coordinate the process between the involved stakeholders, several factors were 
taken into account. Nevertheless, the following difficulties emerged: 
 The level of cooperation between GPs and especially nurses differed between clinics. 
Sometimes there was little will or possibility to cooperate between different 
professional groups.  
 The involved hospitals had different approaches to the treatment of patients, some 
used a standard treatment process, others a case-by-case treatment process. Some 
treated primarily inpatients, others also dealt with outpatients.  
KABEG was conscious that its communication system was not effective. Prior to the 
application of the Renewing Health intervention, all information exchange was based on e-
mails. The communication was neither fast nor efficient enough, as doctors received too 
many e-mails related to their patients under diabetes treatment and it was difficult for 
them to determine which of them reported severe conditions or which events required fast 
response. Moreover, GPs needed to check their mail box very often if they wanted to be up 
to date. Therefore, KABEG modified the communication processes and remodelled the 
system in two ways:  
1. Internal Changes:  
 Implementation of the telemonitoring application: Results from periodic tests 
started to be stored in the patient record of the health information system (HIS). 
They therefore became available to doctors and nurses at any time and location. In 
total, the 193 Type II Diabetes Mellitus patients (older than 18 and HbA1c >= 6.5) 
and the 65 patients diagnosed with COPD who participated in the pilots uploaded 
information into the HIS during a period of 12 months.  
 Day-to-day running of the service: the service had to be provided without the 
patient physically visiting the clinic. Important parameters about their disease status 
had to be assessed to make sure they fell within safe ranges in order to prevent 
sudden or/and critical worsening events. The GP established some thresholds for 
each patient after the initial examination. Those thresholds could be updated and 
re-set by the doctor depending on the patient’s evolution.  
2. External Changes 
 Implementation of the telemonitoring application: Patients were empowered to care 
for themselves and live as independent a life as possible. However, they were not 
always able to carry out the treatment process or identify the worsening conditions 
 26 
 
that needed a fast-response as patients did not always enter all the parameters. In 
order to overcome these constraints, KABEG developed an SMS-based reminder 
system, which was much faster than a web portal or a call centre. This system 
sends patients reminders by SMS when they fail to enter their parameters, and also 
sends emails to physicians if they fail to comply.  
 Day-to-day running of the service: it became possible to make additional contacts 
with patients by telephone. Patients often wished to communicate with their care 
professionals more often than the usual contacts regarding their treatment. 
Practitioners in the outpatient area were not used to dealing with additional reports 
concerning the status of the disease, and clarifications and changes to the routine 
practice were needed in order to enable this. 
2.8 Reimbursement model and economic flow 
KABEG received €400,000 EU funding for Renewing Health which was used mainly for 
implementing the study and managing the project. If Renewing Health is implemented more 
widely in the future, it would be necessary to develop a legal framework which clarifies 
financing sources. The Austrian funding model is complex, and economic flows come from 
different administrative bodies (Federal Government, Region, Insurance Companies). 
Renewing Health involved mainly the outpatient area, which is fully covered by insurance 
companies. This facilitated the implementation of the initiative. Besides, home nursing and 
mobile nursing were supported by the Regional Government, which was fully committed to 
the initiative. The telemedicine services were included in the regular and universal health 
package of services without additional payment, which made it easy to include patients. 
In general, patients had no costs or nearly none. The services were partly free during the 
study. The Call Centre had to be paid by the patients themselves (about 3€ a month), for 
the web portal the patients need to access the internet via PC or Smartphone, so there 
were very low running costs. Active devices, the blood glucose measuring devices and blood 
pressure measuring devices for the web portal patients were free for patients. During the 
project, test strips for the blood glucose measurements were free for the patients who did 
not need to take insulin. For patients who needed insulin, test strips were paid for by the 
health insurance company.  
There is currently no dedicated funding for eHealth or telemonitoring activities. There is on-
going work on creating targeted agreements between the Austrian and the regional 
governments, which might enable and facilitate eHealth implementation (i.e. the Health 
Reform). These targeted agreements will become common practice for all national and 
regional governments and for the health providers in the regions. One of the main goals of 
these agreements is the use of ICTs to facilitate cooperation, coordination and 
understanding among different bodies. The goals defined in these targeted agreements 
have to be achieved by 2016.  
The main cost saving achieved through Renewing Health relates to the reduction of 
inpatient stays. The main beneficiaries of the intervention in terms of economic outcomes 
would therefore be the regional and federal governments, while public insurance 
companies, which also support inpatient care, would not see any economic improvement. 
This means that in order to involve the GPs, an incentive system may be needed.  
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Since major health care reform is pending in Austria, it is not possible to predict what a 
reasonable economic model would look like in the future, since this will largely depend on 
the actual measures taken after the reform. 
3 Transferability 
The case is well documented since it was deployed as part of a European project and public 
reports are accessible through the official project website. Moreover, in 2015 the most 
relevant scientific results obtained in the pilots will continue to be disseminated in relevant 
conferences and publications.  
So far, the services have not been transferred to other regions, although the experts 
involved have been in contact with other regions. KABEG performed a transferability 
assessment during their pilot study. It was based on the positive feedback from 
government, insurance companies, hospital staff and some selected patients.  
The Austrian Health Ministry is aware of the need to implement telemonitoring solutions for 
the treatment of chronic patients throughout its care system and not only in pilots or small-
scale projects (e.g. Carinthia, DiabMemory in Lower Austria). In this context, they created a 
commission to advise on the provision of eHealth related treatment.  
KABEG considered different points of view: 
 Scalability: KABEG expects that results would be similar if the initiative was scaled 
up to country level. They base their opinion on the simple and flexible architecture 
of the system.  Defined Disease Management Processes (DMPs) and information 
transmission through CDA documents facilitate scaling up. Moreover the experience 
of KABEG with supporting the infrastructure can be a driver for implementation in 
other regions.  
On the other hand, the complex funding system in Austria and the absence of a 
clear framework for eHealth services provision could hinder the process. In addition, 
all the regions in Austria are subject to similar organisational restrictions. Although 
this homogeneity could be a barrier, it could also facilitate scaling up. If the 
necessary organisational changes are produced in one region with successful results 
other regions could solve the same problems following the same steps.  
 Generalisability: KABEG is considering the possibility of applying telemonitoring 
solutions for other patients, i.e. not only for those suffering from diabetes or COPD. 
They consider that the successful experience dealing with diabetic patients and the 
established infrastructure may be a catalyst for widening the selection criteria. 
4 Conclusions 
The Renewing Health case in Carinthia represents an integrated care service for diabetes 
and COPD patients. Since it was part of a European Project, KABEG received dedicated 
funding that has helped promote the initiative and commit the different stakeholders of the 
region to the deployment of these services.  
The project was evaluated through a randomised control trial in terms of both patient 
outcomes and economic impact. Regarding the clinical outcome, no major differences were 
found between the group which received the interventions and the control groups. 
Regarding the economic impact, results suggest that savings can be derived from the use 
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of the service, although due to differences in the characteristics of the intervention and 
control groups, the results were not conclusive.  
With regard to the use of ICT by the patients, some differences were apparent. Diabetic 
patients used the system without problems and reported a good experience. In contrast, 
COPD patients (with worse health status) were not able to use the remote monitoring 
system, so monitoring tasks were delegated to the dedicated nurse. In order to provide 
COPD with special support, a dedicated call centre was set up, supported by A1 Telekom 
Austria.  
From a technical standpoint, one of the main objectives of the Carinthian branch of the 
Renewing Health project was to establish and extend a robust infrastructure and an 
integrated treatment process using electronic systems. Before the project started, KABEG 
counted on a set of technology-based services, such as: (1) the collection of common data 
on nursing with mobile devices during home care, (2) clinical records for the outpatient 
area, and (3) HIS support for physicians and nurses. During the course of the project, 
personal health systems were integrated into the architecture in order to support the 
remote collection of medical data. However, the lack of conclusive results obtained during 
the project trials compromise the deployment of such a telemonitoring system and its use 
in general practice. Organisational issues and costs – i.e. not all Active Devices are 
supported by public insurance companies – need to be further explored in order to finally 
bring the telemonitoring service into standard practice, and to keep it up and running. 
The smooth cooperation between the institutions involved at different levels represented a 
good basis for integration of care delivery. Some barriers still need to be solved, such as 
the definition of standards for communication amongst professionals.  
To sum up, Figure 7 shows the main facilitators (Villalba, 2013) that characterise the 
KABEG case, interoperable information systems and policy commitment being the main 
ones. These two drivers are followed by governance mechanisms already set in place to 
foster integrated care, taking into account the focus on patients and national investments 
and funding programmes at a hospital and regional level. Lastly, incentives and financing, 
and engaged professionals play a minor role in this case, but they could hamper the full 
deployment of the initiative at a regional level. 
Figure 7- Facilitators of Renewing Health in Carinthia  
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Annex 
This annex includes the main tables for the impact extracted from reports provided by 
KABEG.  
Table 5 - Primary Clinical Outcomes of Diabetic Patients11 
Outcome 
Measure 
Intervention Control Mean difference 
after 12 month 
between groups 
(95% CI) 
P 
value 
Baseline 
(t1) 
After 12 
months 
(t2) 
Baseline 
(t1) 
After 12 
months 
(t2) 
 Median (SD) 
Median 
  
HbA1c 
 
8.7  
(1.9)  
8.1 
7.5  
(1.5)  
7.2 
8.1  
(1.2)  
8.0 
7.5  
(1.1)  
7.5 
-.6a (-1.3 to 0.05) 
 
.025 
SF-36: Physical 
Functioning 0-
100 Score 
72.5 
(25.2)  
80 
77.1 
(22.3)  
85 
69.2 
(25.8)  
75 
74.9 
(24.1)  
85 
-1.1b (-7.9 to 5.9) .884 
SF-36: Role 
Physical 0-100 
Score 
63.8 
(24.3) 
62.5 
72.5 
(25.1) 
75.0 
58.5 
(29.5) 
56.3 
68.3 
(29.3) 
75.0 
-1.1 (-10.3 to 8.1) .986 
SF-36: Bodily 
Pain 0-100 
Score 
62.2 
(31.0) 
62.0 
66.5 
(30.0) 
64.0 
59.8 
(33.6) 
62.0 
66.7 
(30.9) 
72.0 
-2.7 (-13.0 to 7.7) .793 
SF-36: General 
Health 0-100 
Score 
62.2 
(16.6) 
62.0 
69.4 
(18.8) 
72.0 
62.6 
(19.3) 
64.5 
67.9 
(17.9) 
67.0 
1.9 (-3.9 to 7.7) .154 
SF-36: Vitality 
0-100 Score 
58.4 
(19.3) 
62.5 
63.2 
(19.1) 
68.8 
56.3 
(25.7) 
53.1 
61.6 
(23.6) 
62.5 
-0.5 (-7.0 to 5.9) .869 
SF-36: Social 
Functioning 0-
100 Score 
81.3 
(22.1) 
87.5 
81.3 
(26.6) 
100.0 
80.1 
(23.1) 
87.5 
86.7 
(18.8) 
100.0 
-6.6 (-14.4 to 1.3) .120 
SF-36: Role 
Emotional 0-
100 Score 
70.7 
(24.5) 
75.0 
78.7 
(25.3) 
91.7 
67.5 
(28.2) 
75.0 
77.7 
(28.4) 
100.0 
-2.2 (-12.2 to 7.7) .965 
SF-36: Mental 
Health 0-100 
Score 
72.1 
(18.8) 
80.0 
72.6 
(20.1) 
80.0 
72.2 
(21.7) 
75.0 
76.1 
(19.6) 
80.0 
-3.5 (-9.3 to 2.3) .254 
SF-36: PCS 
Physical 
Component 
Score 
45.1 
(9.9) 
46.1 
47.9 
(9.5) 
49.4 
43.7 
(10.4) 
44.9 
46.3 
(9.6) 
48.0 
.13 (-2.8 to 3.1) .445 
Notes: 
- Data are mean scores (SD) and medians; differences between groups after 12 month were compared by 
using Mann-Whitney-U-tests. 
- a: a negative value indicates a higher improvement for intervention group. 
- b: a negative value in SF-36-differences indicates a higher improvement for control group. 
                                              
11 Internal report provided by KABEG: Deliverable D15.7-1 Final Pilot Evaluation – Carinthia Cluster 1 Version 
1.0 by Renewing Health and KABEG 
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Table 6 - Secondary Clinical Outcomes of Diabetic Patients11 
Outcome 
Measure 
Intervention Control Mean difference 
after 12 month 
between groups 
(95% CI) 
P value 
Baseline 
(t1) 
After 12 
months 
(t2) 
Baseline 
(t1) 
After 12 
months 
(t2) 
 Median(SD)   
Median 
Cholesterol 197.6 
(53.1) 
188.0 
186.1 
(51.3) 
173.0 
186.8 
(37.8) 
188.0 
185.2 
(41.6) 
176.0 
9.9c (-3.0 to 22.9) 
 
.821 
 
LDL-cholesterol  112.1 
(42.5) 
99.0 
107.6 
(44.2) 
92.5 
107.5 
(36.3) 
106.0 
104.3 
(38.7) 
92.5 
1.3 (-10.7 to 13.2 
 
.166 
 
HDL-
cholesterol 
47.1 
(12.6) 
45.5 
48.1 
(16.9) 
45.0 
48.2 
(16.8) 
47.0 
51.3 
(17.6) 
47.5 
-2.1 (-6.3 to 2.2 
 
.773 
 
Weight 90.74 
(20.0) 
88.0 
90.3 
(19.3) 
90.0 
90.2 
(19.0) 
93.0 
89.9 
(19.0) 
91.0 
0.4 (-1.5 to 2.3) 
 
.155 
 
BMI 31.2 
(5.3) 
30.9 
31.2 
(5.3) 
30.9 
31.3 
(6.0) 
31.1 
31.3 
(6.0) 
31.1 
0.05 (-0.6 to 0.7) 
 
.972 
 
Blood Pressure: 
Diastolic 
88.9 
(12.6) 
88.0 
84.8 
(12.6) 
85.0 
86.7 
(12.9) 
88.0 
85.2 
(13.0) 
86.0 
2.5 (-2.3 to 7.4) 
 
.182 
 
Blood Pressure: 
Systolic 
153.7 
(23.1) 
149.0 
148.7 
(23.6) 
145.0 
150.4 
(21.3) 
149.0 
149.3 
(21.1) 
148.0 
 
3.9 (-4.6 to 12.3) 
 
.220 
 
Triglyceride 233.5 
(260.7) 
165.5 
181.4 
(125.2) 
152.5 
155.1 
(78.0) 
141.0 
157.0 
(90.7) 
139.0 
 
54.0 (-15.0 to 123.0) 
 
.057 
 
Notes:  
- Data are mean scores (SD) and medians, differences between groups after 12 month were compared by 
using Mann-Whitney-U-tests. 
- A positive value in SGRQ-differences indicates a higher improvement for intervention group. 
 
 32 
 
Table 7 - SUTAQ Results Diabetic Patients11 
Outcome 
Measure 
Intervention 
after 3 
months 
Intervention 
after 12 months 
Mean difference after 
12 month between t1 
and t2 (95% CI) 
P value 
 Median (SD) 
Median 
  
F1: enhanced care 5.2  
(0.9) 
 5.6 
5.4  
(1.0)  
5.8 
 
-0.11a (-0.3 to 0.9) 
 
.058 
 
F2: increased 
accessibility 
4.9  
(1.1)  
5.3 
5.2  
(1.2)  
5.8 
-0.25a (-0.6 to 0.05) .015 
F3: privacy & 
discomfort scale 
2.4  
(1.2)  
2.3 
2.1  
(1.0)  
2.0 
0.38b (-0.0 to 0.8) .065 
F4: care personnel 
concerns 
2.6  
(1.5)  
2.7 
1.9  
(1.2)  
1.3 
0.64b (0.20 to 1.1) .007 
F5: kit as 
substitution 
3.6  
(1.3)  
4.0 
3.5  
(1.2)  
3.7 
0.13a (-0.3 to 0.6) .590 
F6: satisfaction 5.7  
(0.6)  
6.0 
5.6  
(0.8)  
6.0 
0.01a (-0.2 to 0.2) .734 
Notes: 
- Data are mean scores (SD) and medians; differences between groups after 12 month were compared by 
using Mann-Whitney-U test.  
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Table 8 - Primary Clinical Outcomes of COPD Patients12 
Outcome Measure Intervention Control Mean 
difference 
after 12 
month 
between 
groups 
(95% CI) 
P value 
Baseline 
(t1) 
After 12 
months 
(t2) 
Baseline 
(t1) 
After 12 
months 
(t2) 
 Median (SD) 
Median 
  
SF36-Physical 
Functioning 
48.2 
(24.5) 
45.0 
39.8 
(31.5) 
40.0 
35.0 
(27.4) 
20.0 
22.8 
(15.4) 
30.0 
3.8 (-9.4 to 
16.9) 
.616 
Role Physical 40.7 
(20.0) 
43.8 
35.9 
(25.0) 
31.3 
19.5 
(19.2) 
25.0 
28.9 
(20.9) 
28.1 
-14.2 (-31.1 
to 2.7) 
.156 
SF36-Bodily Pain 55.6 
(28.8) 
52.0 
55.3 
(32.6) 
51.0 
59.1 
(40.2) 
72.0 
52.8 
(39.1) 
41.5 
6.1 (-17.2 to 
29.3) 
.340 
SF36-General 
Health 
49.3 
(14.4) 
45.0 
47.3 
(25.1) 
45.0 
40.1 
(26.7) 
40.0 
36.3 
(21.3) 
33.5 
1.9 (-14.2 to 
18.0) 
.617 
SF36-Vitality 44.0 
(16.4) 
43.8 
44.6 
(27.9) 
40.6 
38.3 
(25.1) 
37.5 
35.5 
(22.4) 
31.3 
3.4 (-14.1 to 
20.9) 
.769 
SF36-Social 
Functioning 
67.4 
(24.4) 
75.0 
61.2 
(33.9) 
62.5 
58.6 
(36.7) 
87.5 
64.1 
(36.8) 
75.0 
-11.7 (-33.0 
to 9.6) 
.263 
SF36-Role 
Emotional 
53.4 
(28.8) 
50.0 
53.7 
(33.6) 
45.8 
27.6 
(28.7) 
25.0 
45.8 
(29.0) 
45.8 
-17.9 (-43.3 
to 7.4) 
.118 
SF36-Mental 
Health 
59.5 
(19.9) 
60.0 
59.6 
(26.7) 
60.0 
53.1 
(26.6) 
60.0 
56.6 
(27.8) 
62.5 
-3.3 (-17.7 
to 11.2) 
1.00 
SF36-PCS Physical 
Component Score 
38.1  
(7.6)  
37.6 
36.1 
(10.3) 
35.2 
35.3 
(11.3) 
34.1 
31.0  
(9.2)  
31.0 
2.3 (-3.3 to 
7.8) 
.412 
SF36-MCS Mental 
Component Score 
41.8 
(11.7) 
40.6 
42.7 
(14.8) 
41.0 
35.0 
(13.1) 
36.4 
41.0 
(14.6) 
42.9 
-5.1 (-14.6 
to 4.5) 
.292 
Notes: 
- Data are mean scores (SD) and medians, differences between groups after 12 month were 
compared by using Mann-Whitney-U-tests All scores are 1 - 100 
- A negative value in SF-36-differences indicates a higher improvement for control group 
 
 
                                              
12 Internal deliverable provided by KABEG: Deliverable D15.7-5 Final Pilot Evaluation – Carinthia Cluster 5 
Version 0.4 by Renewing Health and KABEG 
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Table 9 - Primary Clinical Outcomes of COPD Patients12 
Saint George’s 
Questionnaire  
Outcome Measure 
Intervention Control Mean 
difference 
after 12 month 
between groups 
(95% CI) 
P value 
Baseline 
(t1) 
After 12 
months 
(t2) 
Baseline 
(t1) 
After 12 
months 
(t2) 
 Median (SD) 
Median 
  
Symptoms score  69.0 
(18.0) 
72.7 
61.2 
(27.6) 
66.0 
74.0 
(20.1) 
70.8 
67.4 
(24.2) 
73.3 
1.3 (-19.0 to 
21.5) 
.721 
Activity score  68.9 
(22.9) 
75.8 
62.4 
(28.4) 
69.4 
76.3 
(17.2) 
77.8 
79.3 
(13.5) 
79.1 
9.5 (-3.5 to 22.6) .315 
Impacts score  42.6 
(20.9) 
42.8 
42.3 
(23.3) 
47.2 
55.1 
(17.9) 
57.2 
54.3 
(20.1) 
55.6 
-0.5 (-14.4 to 
13.4) 
.989 
Total score  54.6 
(18.1) 
56.4 
50.8 
(24.0) 
57.7 
64.8 
(15.3) 
65.4 
64.2 
(17.7) 
64.6 
3.2 (-9.8 to 16.3) .849 
Notes:  
- Data are mean scores (SD) and medians, differences between groups after 12 month were 
compared by using Mann-Whitney-U-tests. 
- A positive value in SGRQ-differences indicates a higher improvement for intervention group. 
 
 
Table 10 - SUTAQ Results COPD patients12 
Outcome 
Measure 
Intervention after 
3 months 
 
Intervention after 
12 months 
Mean difference 
after 12 month 
between t1 and t2 
(95% CI) 
P value 
 Median (SD) 
Median 
  
F1: enhanced 
care  
5.3 (0.8) 5.6 4.7 (1.1) 4.8 0.58a (-0.0 to 1.2) .036 
F2: increased 
accessibility  
4.8 (1.1) 4.9 4.4 (1.5) 4.9 0.32a (-0.6 to 1.2) .432 
F3: privacy & 
discomfort 
scale  
2.5 (1.4) 2.3 2.5 (1.5) 2.3 0.08b (-1.0 to 1.2) .656 
F4: care 
personnel 
concerns  
2.6 (1.8) 1.3 2.2 (1.4) 2.0 0.46b (-1.0 to 1.9) .568 
F5: kit as 
substitution  
3.4 (1.3) 3.3 2.8 (1.3) 2.7 0.58a (-0.1 to 1.3) .098 
F6: satisfaction  5.6 (0.6) 6.0 5.5 (0.6) 6.0 0.06a (-0.2 to 0.3) .673 
Notes: 
- Data are mean scores (SD) and medians; differences between t1 (after 3 months) and t2 (after 12 months) 
were compared by using Wilcoxon tests. 
 a: a negative value in SUTAQ differences indicates a higher agreement with the aspects of 
the kit at t2. 
 b: a positive value in SUTAQ differences indicates a higher agreement with the aspects of 
the kit at t2 
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Table 11 - Types of resources included in the estimation of costs 
Type of Costs Method of Data 
Collection 
Estimation at patient 
or group level 
Investment in the telemedicine application 
 Education of Staff Questionnaire to staff Group level 
Running Costs 
Intramural Area time used by staff - education 
of patients 
interview with staff, 
documentation 
Patient level 
time used by staff - medical 
treatments 
number of telemedicine 
visitations 
HIS-System 
 
Transmission standard rate special devices documentation 
standard rate internet portal 
Travelling 
expenses 
km home-hospital Patients data 
km home-doctor 
Persons time time used by patient Questionnaire, patient 
Time used by relatives 
Effects on patient use of health care  
Intramural Area Number of outpatient visits HIS-System Patient level 
Number of inpatient days 
Inpatient days per stay 
Extramural Area Number of contacts with GP Questionnaire patients 
Number of contacts with 
consultant 
Number of contacts with 
emergency doctor 
Number of stays in other 
hospitals (not KABEG) 
Table 12 - Analysis of cost differences11 
Case Number of 
Patients 
Total cost 
intervention 
group 
 (per patient) 
Total cost control 
group 
(per patient) 
Mean difference 
DIABETES 
Base Case 193 2,006€ 2,121€ -115€ 
Men 110 2,022€ 2,157€ -135€ 
Women 83 1,988€ 2,067€ -79€ 
Patients aged >70 37 1,548€ 1,571€ -23€ 
Patients aged<71 156 2,103€ 2,283€ -180€ 
COPD 
Base Case 65 6056.73€ 2,121€ -1617.90€ 
Men 44 5580.53 € 2,157€ -112.38€ 
Women 21 7186.59€ 2,067€ -2249.20€ 
Patients aged >70 19 5651.76€ 1,571€ -3966.14€ 
Patients aged<71 156 2,103€ 2,283€ -3374.68€ 
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Table 13 - Cost of different services for different groups (Rounded values) 11 
 Cost of 
outpatient visits 
Cost of 
inpatient stays 
Costs of GP Cost of Medical 
specialists 
DIABETES 
Base case  
Intervention 122 1245 71 43 
Control 114 1794 65 59 
Men 
Intervention 94 1291 75 43 
Control 129 1808 64 68 
Women 
Intervention 141 1188 66 43 
Control 94 1773 67 45 
Aged>70 
Intervention 70 767 95 42 
Control 78 1178 105 123 
Aged<71 
Intervention 124 1344 67 43 
Control 125 1971 55 43 
COPD 
Base case      
Intervention 122 5143 88 192 
Control 36 7180 120 138 
Men     
Intervention 93 4700 99 176 
Control 11 6237 104 140 
Women     
Intervention 191 6188 51 245 
Control 80 8877 142 136 
Aged>70     
Intervention 67 9687 82 278 
Control 38 6170 130 121 
Aged<71     
Intervention 127 4742 89 182 
Control 33 8526 109 158 
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